A variety of anti-HMGA1 strategies, including small molecules, anti-sense mRNA expression, miRNA expression, and siRNA delivery, have demonstrated promising anti-tumor effects using transformed cells in in vitro systems and xenograft models [20–42]. Here, HMGA1 is linked to neoplasm.